Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
vax014 (2 trials)
Carcinoma, Transitional Cell (Phase 1)
Urinary Bladder Neoplasms (Phase 1)
Trials (2 total)
Trial APIs (1 total)